Skip to main content
رجوع
ATAI logo

Atai Beckley N.V

جودة البيانات: 100%
ATAI
NASDAQ Healthcare Medical - Pharmaceuticals
KWD 3.39
▼ KWD 0.10 (-2.87%)
القيمة السوقية: 639.44M
نطاق اليوم
KWD 3.37 KWD 3.57
نطاق 52 أسبوعًا
KWD 1.15 KWD 6.75
حجم التداول
5,301,410
متوسط 50 يوم / 200 يوم
KWD 3.80 / KWD 4.04
الإغلاق السابق
KWD 3.49

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (626 نظير)

المقياس السهم وسيط القطاع
P/E -4.3 0.4
P/B 5.5 2.9
ROE % -83.1 3.7
Net Margin % -48464.0 3.9
Rev Growth 5Y % 10.0
D/E 0.2 0.2

السعر المستهدف للمحللين

Hold
KWD 11.750 +246.6%
Low: KWD 10.000 High: KWD 14.000
ربحية السهم المستقبلية
-KWD 0.477
الإيرادات المقدّرة
470000

تقديرات الأرباح

الفترة تقدير ربحية السهم تقدير الإيرادات المحللون
FY2030 KWD 0.233
KWD 0.233 – KWD 0.233
440 M 4
FY2029 -KWD 0.261
-KWD 0.261 – -KWD 0.261
190 M 4
FY2028 -KWD 0.471
-KWD 0.770 – -KWD 0.290
20 M 10

النقاط الرئيسية

Debt/Equity of 0.21 — conservative balance sheet
Negative free cash flow of -82.53M
Capital intensive — 30.84% of revenue goes to capex

النمو

Revenue Growth (5Y)
N/A
Revenue (1Y)-1.91%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-83.10%
ROIC-54.62%
Net Margin-48463.96%
Op. Margin-33341.23%

الأمان

Debt / Equity
0.21
Current Ratio3.21
Interest Coverage-32.87

التقييم

P/E Ratio
-4.28
P/B Ratio5.50
EV/EBITDAN/A
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) -1.91% Revenue Growth (3Y) 14.97%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 308,000.0 Net Income (TTM) -149.27M
ROE -83.10% ROA -93.65%
Gross Margin 100.00% Operating Margin -33341.23%
Net Margin -48463.96% Free Cash Flow (TTM) -82.53M
ROIC -54.62% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.21 Current Ratio 3.21
Interest Coverage -32.87 Dividend Yield 0.00%
Valuation
P/E Ratio -4.28 P/B Ratio 5.50
P/S Ratio 2076.10 PEG Ratio -0.01
EV/EBITDA N/A Dividend Yield 0.00%
Market Cap 639.44M Enterprise Value 646.64M

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Revenue 308,000.0 314,000.0 233,000.0 20.38M 0.0
Net Income -149.27M -40.22M -152.39M -167.81M -169.84M
EPS (Diluted) -0.93 -0.25 -0.91 -0.83 -0.67
Gross Profit 308,000.0 314,000.0 233,000.0 20.38M 0.0
Operating Income -102.69M -125.47M -144.79M -135.81M -104.16M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Total Assets 159.39M 293.48M 305.44M 414.17M 111.55M
Total Liabilities 42.83M 49.16M 39.68M 28.21M 16.18M
Shareholders' Equity 116.30M 242.96M 260.74M 376.91M 90.82M
Total Debt 24.71M 19.14M 15.34M 743,000.0 2.18M
Cash & Equivalents 17.51M 45.03M 190.61M 362.27M 97.25M
Current Assets 80.13M 185.59M 287.15M 375.08M 99.55M
Current Liabilities 24.95M 20.12M 19.90M 20.94M 12.30M